Patents by Inventor HistoRx, Inc.

HistoRx, Inc. has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20130310268
    Abstract: Methods and apparatus for standardizing quantitative measurements from a microscope system. The process includes a calibration procedure whereby an image of a calibration slide is obtained through the optics of the microscope system. The calibration slide produces a standard response, which can be used to determine a machine intrinsic factor for the particular system. The machine intrinsic factor can be stored for later reference. In use, images are acquired of a target sample and of the excitation light source. The excitation light source sample is obtained using a calibration instrument configured to sample intensity. The calibration instrument has an associated correction factor to compensate its performance to a universally standardized calibration instrument. The machine intrinsic factor, sampled intensity, and calibration instrument correction factor are usable to compensate a quantitative measurement of the target sample in order to normalize the results for comparison with other microscope systems.
    Type: Application
    Filed: April 22, 2013
    Publication date: November 21, 2013
    Applicant: HistoRx, Inc.
    Inventor: HistoRx, Inc.
  • Publication number: 20130216111
    Abstract: The present invention relates generally to improved methods of defining areas or compartments within which biomarker expression is detected and quantified. In particular, the present invention relates to automated methods for delineating marker-defined compartments objectively with minimal operator intervention or decision making. The method provides for precise definition of tissue, cellular or subcellular compartments particularly in histological tissue sections in which to quantitatively analyzing protein expression.
    Type: Application
    Filed: December 14, 2012
    Publication date: August 22, 2013
    Applicant: HistoRx, Inc.
    Inventor: HistoRx, Inc.
  • Publication number: 20130143763
    Abstract: The method of the invention pertains to determining signal transduction activity in a tissue section by immunohistochemistry techniques. The expression level of the receptor of interest is determined as well as the expression levels of one or more effector molecules of the receptor signal transduction pathway. Furthermore a combined ratio of expression levels of effector molecules in subcellular compartments with the receptor expression was found to have prognostic significance.
    Type: Application
    Filed: February 5, 2013
    Publication date: June 6, 2013
    Applicants: YALE UNIVERSITY, HISTORX, INC.
    Inventors: HistoRx, Inc., Yale University